Position in MDXG
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$11,928,490
-$4,773,540 QoQ
Shares Held
3,019,871
+22.4% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. MDXG ranks #43 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in MDXG
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,928,490 | 3,019,871 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,702,030 | 2,467,065 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $14,017,424 | 2,008,227 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,878,517 | 2,107,777 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $14,670,105 | 1,930,277 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,359,838 | 1,804,557 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,008,199 | 1,524,230 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,884,154 | 1,570,585 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $13,525,704 | 1,756,585 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,978,154 | 1,251,785 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,895,689 | 1,083,085 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,951,544 | 900,385 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,999,384 | 879,585 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,642,104 | 590,685 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,596,824 | 556,385 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,221,011 | 640,061 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,471,333 | 312,385 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,076,932 | 178,300 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $694,476 | 114,600 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,683,846 | 134,600 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $850,780 | 82,600 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $442,196 | 48,700 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||